OLMA
Olema Pharmaceuticals, Inc.
Recent 8-K filings for OLMA
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 12, 2026 11:05 UTC earnings item 2.02item 9.01
Olema reports Q1 net loss $53.1M, cash $505.3M; Phase 3 OPERA-01 data due fall 2026
source · OLMA on sec.gov